Maxx Orthopedics commenced commercial launch and announced first successful surgeries using its new Libertas® Taper Reduced (TR) Uncemented Femoral Stem.
Libertas TR is a press fit, double tapered stem with Ti-GrowthC® coating offered in standard and distally reduced versions. The stems are available in three neck angles to accommodate patient-specific anatomic requirements and are compatible with Maxx’s existing Libertas Femoral Heads, as well as the Libertas Acetabular Cup. The proximal Ti-GrowthC coating on the implant surface is designed to promote biological integration with bone for longer-term stability, while the geometry of the stem aids in providing a better fit for proximal and distal mismatches.
“[The] Libertas TR is in limited release now, and we expect full commercial release within three months. As a company this launch is particularly invigorating as we continue to battle the challenges posed by COVID-19,” said Ashesh Shah, Chief Executive Officer.